ReviewDiscover oncology2025

The safety and efficacy of encorafenib plus binimetinib for brain metastases: a systematic review and meta-analysis.

Amirmohammad Bahri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.